Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

Signal transduction in mammary tumorigenesis: a transgenic perspective

Oncogene volume 19, pages 1038–1044 (2000)Cite this article

Abstract

A number of genes have been implicated in breast cancer development, yet few have been demonstrated to play causative roles in mammary tumor formation. The advent of transgenic mouse and embryonic stem cell technologies now permits manipulation of the mouse genome in such a way as to temporally and spatially control a gene product's expression. Thus, the basic researcher now can directly assess the involvement of particular genes in tumorigenesis and disease progression and, in the process, to develop mouse models of human genetic disease. The utility of such technologies is emphasized in transgenic mice expressing genes thought to play important roles in the initiation and progression of mammary carcinomas. As these transgenic strains have been the subject of several reviews, here we focus on two mouse mammary tumor models, Polyomavirus middle T antigen and the Neu/ErbB-2 receptor tyrosine kinase, which are most amenable to study specific signaling pathways in process of mammary tumorigenesis.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  • Allred DC, Clark GM, Molina R, Tandon AK, Schnitt SJ, Gilchrist KW, Osborne CK, Tormey DC and McGuire WL. . 1992 Human Path. 23: 974–979.

  • Almandi M, Romano A, Curia MC, Muraro R, Fedi P, Aaronson SA, DiFiore PP and Kraus MH. . 1995 Oncogene 10: 1813–1821.

  • Amundadottir LT, Merlino G and Dickson RB. . 1996 Breast Cancer Res. Treat. 39: 119–135.

  • Andres A-C, Schonenberger C-A, Groner B, Henninghausen L, LeMeur M and Gerlinger P. . 1987 Proc. Natl. Acad. Sci. USA 84: 1299–1303.

  • Andrulis IL, Bull SB and Group TBCS. . 1998 J. Clin. Oncol. 16: 1340–1349.

  • Bartkova J, Lukas J, Muller H, Lutzhoft D, Strauss M and Bartek J. . 1994 Int. J. Cancer 57: 353–361.

  • Ben-Levy R, Paterson HF, Marshall CJ and Yarden Y. . 1994 EMBO J. 13: 3302–3311.

  • Berebbi M, Martin PM, Berthois Y, Bernard AM and Blangy D. . 1990 Oncogene 5: 505–509.

  • Berns EMJJ, Klijn JGM, van Putten WLJ, van Staveren IL, Portengen H and Foekens JA. . 1992 Cancer Res. 52: 1107–1113.

  • Bos JL. . 1989 Cancer Res. 49: 4862–4869.

  • Bouchard L, Lamarre L, Trembley PJ and Jolicoeur P. . 1989 Cell 57: 931–936.

  • Buckley MF, Sweeney KJE, Hamilton JA, Sini RL, Manning DL, Nicholson RI, deFazio A, Watts CKW, Musgrove EA and Sutherland RL. . 1993 Oncogene 8: 2127–2133.

  • Buday L and Downward J. . 1993 Cell 73: 611–620.

  • Campbell KS, Ogris E, Burke B, Su W, Auger KR, Druker BJ, Schaffhausen BS, Roberts TM and Pallas DC. . 1994 Proc. Natl. Acad. Sci. USA 91: 6344–6348.

  • Campbell SL, Khosravi-Far R, Rossman KL, Clark GJ and Der CJ. . 1998 Oncogene 17: 1395–1413.

  • Cardiff RD and Muller WJ. . 1993 Cancer Surv. 16: 97–113.

  • Carraway III KL, Soltoff SP, Diamonti AJ and Cantley LC. . 1995 J. Biol. Chem. 270: 7111–7116.

  • Chardin P, camonis JH, Gale NW, Aelst LV, Schlessinger J, Wigler NH and Bar-Sagi D. . 1993 Science 260: 1338–1343.

  • Charmichel G, Schaffhausen BS, Mandel G, Liang TJ and Benjamin TL. . 1984 Proc. Natl. Acad. Sci. USA 81: 679–683.

  • Cheng A, Saxton TM, Sakai R, Mbamalu G, Vogel W, Tortorice C, Cardiff RD, Cros JC, Muller WJ and Pawson T. . 1998 Cell 95: 793–804.

  • Cheng SH, Harvey R, Espino PC, Semba K, Yamanota T, Toyoshima K and Smith AE. . 1988 EMBO J. 7: 3845–3855.

  • Courtneidge SA and Smith AE. . 1983 Nature 303: 435–439.

  • Daly RJ, Binder MD and Sutherland RL. . 1994 Oncogene 9: 2723–2727.

  • Dankort DL and Muller WJ. . 1996 In: Mammary Tumor Cell Cycle, Differentiation and Metastasis. Dickson R and Lippman M. (eds)..

  • Dankort DL, Wang Z, Blackmore V, Moran MF and Muller WJ. . 1997 Mol. Cell. Biol. 17: 5410–5425.

  • Dilworth SM, Brewster CEP, Jones MD, Lanfrancone L, Pelicci G and Pelicci PG. . 1994 Nature 367: 87–90.

  • Dobashi K, David JG, Mikami Y, Freeman JK, Hamuro J and Greene MI. . 1991 Proc. Natl. Acad. Sci. USA 88: 8582–8586.

  • Dougall WC, Qian X, Miller MJ and Greene MI. . 1996 DNA and Cell. Biol. 15: 31–40.

  • Druker BJ, Sibert L and Roberts TM. . 1992 J. Virol. 66: 5770–5776.

  • Dudek H, Datta SR, Franke TF, Birnbaum MJ, Yao R, Cooper GM, Segal RA, Kaplan DR and Greenberg ME. . 1997 Science 275: 661–664.

  • Dupont WD and Page DL. . 1985 N. Engl. J. Med. 312: 146–151.

  • Egan SE, Giddings BW, Brooks MW, Buday L, Sizeland AM and Weinberg RA. . 1993 Nature 360: 45–51.

  • Fazioli F, Kim U-H, Rhee SG, Molloy CJ, Segatto O and DiFiore PP. . 1991 Mol. Cell. Biol. 11: 2040–2048.

  • Fearon ER and Vogelstein B. . 1990 Cell 61: 759–767.

  • Galaktionov K, Lee AK, Eckstein J, Draetta G, Meckler J, Loda M and Beach D. . 1995 Science 269: 1575–1577.

  • Gale NW, Kaplan S, Lowenstein EJ, Schlessinger J and Bar-Sagi D. . 1993 Nature 363: 88–92.

  • Gasparini G, Bevilacqua, Pozza F, Meli S, Boracchi P, Marubini E and Sainsbury JRC. . 1992 Br. J. Cancer 66: 970–976.

  • Gotoh N, Toyoda M and Shibuya M. . 1997 Mol. Cell. Biol. 17: 1824–1831.

  • Guy CT, Cardiff RA and Muller WJ. . 1992a Mol. Cell. Biol. 12: 954–961.

  • Guy CT, Cardiff RA and Muller WJ. . 1996 J. Biol. Chem. 271: 7673–7678.

  • Guy CT, Muthuswamy SK, Cardiff RA, Sariano P and Muller WJ. . 1994 Genes Dev. 8: 23–32.

  • Guy CT, Webster MA, Schaller M, Parsons TJ, Cardiff RA and Muller WJ. . 1992b Proc. Natl. Acad. Sci. USA 89: 10578–10582.

  • Heldin C-H. . 1995 Cell 80: 213–222.

  • Hynes NE and Stern DF. . 1994 Biochim. Biophys. Acta. 1198: 165–184.

  • Israel MA, Simmons DT, Hourian SL, Rowe WP and Martin MA. . 1979 Proc. Natl. Acad. Sci. USA 76: 3713–3716.

  • Jacobs C and Rubsamen H. . 1983 Cancer Res. 43: 1696–1702.

  • Jallal B, Schlessinger J and Ullrich A. . 1992 J. Biol. Chem. 267: 4357–4363.

  • Janes PW, Daly RJ, deFazio A and Sutherland RL. . 1994 Oncogene 9: 3601–3608.

  • Jelinek MA and Hassell JA. . 1992 Oncogene 7: 1687–1698.

  • Kaplan DR, Pallas DC, Morgan B, Schaffhausen B and Roberts TM. . 1988 Biochem. Biophys. Acta. 948: 345–364.

  • Katz ME and McCormick F. . 1997 Curr. Opin. Genet. Dev. 7: 75–79.

  • Kennedy SG, Wagner AJ, Conzen SD, Jordan J, Bellacosa A, Tsichlis PN and Hay N. . 1997 Genes Dev. 11: 701–713.

  • Khwaja A, Rodriguez-Viciana P, Wennstrom S, Warne PH and Downward J. . 1997 EMBO J. 16: 2783–2793.

  • Kornbluth S, Sueul M and Hanafusa H. . 1986 Nature 325: 171–173.

  • Krane IM and Leder P. . 1996 Oncogene 12: 1781–1788.

  • Kuaffmann-Zeh A, Rodriguez-Viciana P, Ulrich E, Gilbert C, Coffer P, Downward J and Evan G. . 1997 Nature 385: 544–548.

  • Kulik G, Klippel A and Weber MJ. . 1997 Mol. Cell. Biol. 17: 1595–1606.

  • Kypta RM, Hemming A and Courtneidge SA. . 1988 EMBO J. 7: 3837–3844.

  • Lemoine NR, Staddon SC, Barnes M and Gullick WJ. . 1990 Oncogene 5: 237–239.

  • Li N, Batzer A, Daly R, Yajnik V, Skolnik E, Chardin P, Bar-Sagi D, Margolis B and Schlessinger J. . 1993 Nature 363: 85–88.

  • Luchini F, Sacco MG, Hu N, Villa A, Brown J, Cesano L, Mangiarini L, Rindi G, Kindl S, Sessa F, Vezzoni P and Clerici L. . 1992 Cancer Lett 64: 203–209.

  • Lupu R, Colomer R, Kannan B and Lippman ME. . 1992 Proc. Natl. Acad. Sci. USA 89: 2287–2291.

  • Luttrell DK, Lee A, Lansing TJ, Crosby RM, Jung KD, Willard D, Luther M, Rodriguez M, Berman J and Gilmer TM. . 1994 Proc. Natl. Acad. Sci. USA 91: 83–97.

  • Luttrell DK, Luttrell LM and Parsons SJ. . 1988 Mol. Cell. Biol. 8: 497–501.

  • Maa MC, Leu T-H, McCarley DJ, Schatzman RC and Parsons SJ. . 1995 Proc. Natl. Acad. Sci. USA 92: 6981–6985.

  • Mansour EG, Ravdin PM and Dressler L. . 1994 Cancer 74: 381–400.

  • Markland W, Oostra BA, Harvey R, Markham AF, Colledge WH and Smith AE. . 1986 J. Virol. 59: 384–391.

  • Markland W and Smith AE. . 1987 Biochim. Biophys. Acta. 907: 299–321.

  • Matsui Y, Halter SA, Holt JT, Hogan BLM and Coffey RJ. . 1990 Cell 61: 1147–1155.

  • McGlade J, Cheng A, Pelicci G, Pelicci PG and Pawson T. . 1992 Proc. Natl. Acad. Sci. 89: 8869–8873.

  • Mikami Y, Davis JG, Dobash K, Dougall WC, Myers JN, Brown VI and Greene MI. . 1992 Proc. Natl. Acad. Sci. USA 89: 7335–7339.

  • Morrison BW. . 1994 Hem./Oncol. Clin. N. Am. 8: 15–27.

  • Muller WJ, Arteaga CL, Muthuswamy SK, Siegel PM, Webster MA, Cardiff RD, Meise KS, Li F, Halter SA and Coffey RJ. . 1996 Mol. Cell. Biol. 16: 5726–5736.

  • Muller WJ, Sinn E, Pattengale PK, Wallace R and Leder P. . 1988 Cell 54: 105–115.

  • Muthuswamy SK and Muller WJ. . 1995 Oncogene 11: 271–279.

  • Muthuswamy SK, Siegel PS, Dankort DL, Webster MA and Muller WJ. . 1994 Mol. Cell. Biol. 14: 735–743.

  • Nielsen LL, Discafani CM, Gurnani M and Tyler RD. . 1991 Cancer Research 51: 3762–3767.

  • Ogg S and Ruvkun G. . 1998 Mol. Cell. 2: 887–893.

  • Ottenhoff-Kalff AE, Rijksen G, van Beurden EACM, Hennipman A, Michels AA and Staal GEJ. . 1992 Cancer Res. 52: 4773–4778.

  • Patchefsky AS, Schwartz GF, Finkelstein SD, Prestipino A, Sohn SE, Singer JS and Feig SA. . 1989 Cancer 63: 731–741.

  • Pawson T and Scott JD. . 1997 Science 278: 2075–2080.

  • Peles E, Lamprecht R, Ben Levy R, Tzahar E and Yarden Y. . 1992 J. Biol. Chem. 267: 12266–12274.

  • Pellici G, Lanfracone L, Salcini AE, Romano A, Simonetta M, Borrello MG, Segatto O, DiFore PP and Pellici PG. . 1995 Oncogene 11: 899–907.

  • Prigent SA and Gullick WJ. . 1994 EMBO J. 13: 2831–2841.

  • Ravdin PM. . 1995 Gene 159: 19–27.

  • Rochlitz CF, Scott GK, Dodson JM, Liu E, Dollbaum C, Smith HS and Benz CC. . 1989 Cancer Res. 49: 357–360.

  • Rosen N, Bolen JB, Schwartz AM, Cohen P, DeSeau V and Isreal MA. . 1996 J. Biol. Chem. 2261: 11754–11759.

  • Rozakis-Adcock M, Fernley R, Wade J, Pawson T and Bowtell D. . 1993 Nature 363: 83–85.

  • Rozakis-Adcock M, McGlade J, Mbamalu G, Pelicci G, Daly R, Li W, Batzer A, Thomas S, Brugge J, Pelicci PG, Schlessinger J and Pawson T. . 1992 Nature 360: 689–692.

  • Sadowski I, Stone JC and Pawson T. . 1986 Mol. Cell. Biol. 6: 4396–4408.

  • Sainsbury JRC, Nicholson S, Angus B, Farndon JR, Malcolm AJ and Harris AL. . 1988 Br. J. Cancer 58: 458–460.

  • Salcini AE, McGlade J, Pelicci G, Nicoletti I, Pawson T and Pelicci PG. . 1994 Oncogene 9: 2827–2836.

  • Samanta A, LeVea CM, Dougall WC, Qian X and Greene MI. . 1994 Proc. Natl. Acad. Sci. USA 91: 1711–1715.

  • Sandgren EP, Luetteke NC, Palmiter RD, Brinster RL and Lee DC. . 1990 Cell 61: 1121–1135.

  • Scheele JS, Rhee JM and Boss GR. . 1995 Proc. Natl. Acad. Sci. USA 92: 1097–1100.

  • Schuuring E, Verhoeven E, Litvinov S and Michalides RJAM. . 1993 Mol. Cell. Biol. 13: 2891–2898.

  • Schuuring E, Verhoeven E, van Tinteren H, Peterse JL, Nunnink B, Thunnissen FBJM, Devilee P, Cornelisse CJ, van der Vijver MJ and Mooi WJ. . 1992 Cancer Res. 52: 5229–5234.

  • Scott GK, Dodson JM, Montgomery PA, Johnson RM, Sarup JC, Wong WL, Ullrich A, Shepard HM and Benz CC. . 1991 J. Biol. Chem. 266: 14300–14305.

  • Segatto O, Lonardo F, Helin K, Wexler D, Fazioli F, Rhee SG and Di Fiore PP. . 1992 Oncogene 7: 1339–1346.

  • Segatto O, Lonardo F, Pierce JH, Bottaro DP and Di Fiore PP. . 1990 New Biologist 2: 187–195.

  • Sepp-Lorenzino L, Eberhard I, Ma Z, Cho C, Serve H, Liu F, Rosen N and Lupo R. . 1996 Oncogene 12: 1679–1687.

  • Siegel PM, Dankort DL, Hardy WR and Muller WJ. . 1994 Mol. Cell. Biol. 14: 7068–7077.

  • Siegel PM, Ryan ED, Cardiff RD and Muller WJ. . 1999 EMBO J. 18: 2149–2164.

  • Sinn E, Muller W, Pattengale P, Tepler I, Wallace R and Leder P. . 1987 Cell 49: 465–475.

  • Slamon DJ, Clark GM, Wong SG, Levin WJ, Ullrich A and McGuire WL. . 1987 Science 235: 177–182.

  • Slamon DJ, Godolphin W, Jones LA, Holt JA, Wong SG, Keith DE, Levin WJ, Stuart SG, Udove J, Ullrich A and Press MF. . 1989 Science 244: 707–712.

  • Soltoff SP, Carraway III KL, Prigent SA, Gullick WJ and Cantley LC. . 1994 Mol. Cell. Biol. 14: 3550–3558.

  • Songyang Z, Shoelson SE, McGlade J, Olivier P, Pawson T, Bustelo XR, Barbacid M, Sabe H, Hanafusa H, Yi T, Ren R, Baltimore D, Ratnofsky S, Feldman RA and Cantley LC. . 1994 Mol. Cell. Biol. 14: 2777–2785.

  • Stein D, Wu J, Fuqua SA, Roonprapunt C, Yajnik V, D'Eustachio P, Moskow JJ, Buchberg AM, Osborne CK and Margolis B. . 1994 EMBO J. 13: 1331–1340.

  • Stocklin E, Botteri F and Groner B. . 1993 J. Cell. Biol. 122: 199–208.

  • Sudol M. . 1998 Oncogene 17: 1469–1474.

  • Tzahar E and Yarden Y. . 1998 Biochim. Biophys. Acta. 1377: M25–M37.

  • Van der Geer P, Wiley S, Lai VK-M, Olivier JP, Gish GD, Stephens R, Kaplan D, Shoelson S and Pawson T. . 1995 Curr. Biol. 5: 404–412.

  • Vogelstein B and Kinzler KW. . 1993 Trends Genetics 9: 138–141.

  • Wallasch C, Weib FU, Niederfellner G, Jallal B, Issing W and Ullrich A. . 1995 EMBO J. 14: 4267–4275.

  • Webster MA, Cardiff RD and Muller WJ. . 1995 Proc. Natl. Acad. Sci. USA 92: 7849–7853.

  • Webster MA, Hutchinson JN, Rauh MA, Muthuswamy SK, Anton M, Tortorice CG, Cardiff RD, Graham FL, Hassell JA and Muller WJ. . 1998 Mol. Cell. Biol. 18: 2344–2359.

  • Wu K, Salas PJI, Yee L, Fregien N and Carraway K. . 1994 Oncogene 9: 3139–3147.

  • Yao R and Cooper GM. . 1995 Science 267: 2003–2006.

  • Zhou DJ, Casey G and Cline MJ. . 1988 Oncogene 2: 279–282.

  • Zoll B, Kynast B, Corell B, Marx D, Fischer G and Schauer A. . 1992 J. Cancer Res. Clin. Oncol. 118: 468–473.

Download references

Acknowledgements

This work was supported by the Canadian Breast Cancer Initiative, US Army, Medical Research Council of Canada. WJ Muller is a Medical Research Council of Canada Scientist.

Author information

Authors and Affiliations

  1. Department of Biology, Institute for Molecular Biology and Biotechnology, McMaster University, 1280 Main St. West, Hamilton, L8S 4K1, Ontario, Canada

    David L Dankort & William J Muller

  2. Department of Pathology, Institute for Molecular Biology and Biotechnology, McMaster University, 1280 Main St. West, Hamilton, L8S 4K1, Ontario, Canada

    William J Muller

Authors
  1. David L Dankort
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. William J Muller
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Dankort, D., Muller, W. Signal transduction in mammary tumorigenesis: a transgenic perspective. Oncogene 19, 1038–1044 (2000). https://doi.org/10.1038/sj.onc.1203272

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1203272

Keywords

This article is cited by

Search

Advanced search

Quick links